RetroVirox

About:

RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases

Website: http://retrovirox.com

Top Investors: National Institutes of Health

Description:

RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious disease. RetroVirox offers its expertise in antiviral assays and cell-based screening for antiviral compounds to other biotechnology and pharmaceutical companies.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)retrovirox.com

Founders:

Enric Bernal, Juan Lama

Number of Employees:

1-10

Last Funding Date:

2015-03-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai